1887

n South African Medical Journal - GeneXpert TB 8 : a point-of-care diagnostic pilot : correspondence

USD

 

Abstract

The point-of-care (POC) GeneXpert MTB/RIF detects (MTB) and drug resistance in under 2 hours and was hailed a 'game-changer' for tuberculosis (TB) control. Recent results from Evaluating a New Diagnostic Trial (EXTEND) show that while implementing the GeneXpert had more confirmations of TB than sputum microscopy, levels of loss to follow-up and mortality were not reduced in the GeneXpert group. These results are discouraging. However, GeneXpert was not used as a true POC service. Using the diagnostic at POC, where results are handed to patients at the time and place of sample collection, may yield different outcomes.

Loading

Article metrics loading...

/content/m_samj/104/8/EJC156362
2014-08-01
2016-12-09
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error